Federal records show that over 90 million COVID-19 vaccines have arrived in Canada.
As Blacklock’s Reporter first reported, “under Canada’s pre-purchase agreement, there are currently 90.8 million doses remaining to be supplied in 2023 and 2024,” the Department of Public Works said. ) reported.
Pricing was not disclosed, according to reports. Canadian Audit Office (OAG) Estimate in the report December of last year The average cost of one dose was about $30. That means it will cost the country about $2.72 billion when the rest of the dose finally arrives.
“The agreement will give us the flexibility to procure the latest formulations and presentations of Covid-19 vaccines, including those designed to protect against mutations and variants of concern and those developed for younger populations.” The report entitled ‘Answers to the Questions Informed’.
“Booster doses could be obtained with 90.8 million doses to be delivered in 2023 and 2024.”
The remaining dosages include 30 million doses from Pfizer Canada, 42.3 million doses from Novovax and 18.5 million doses from Moderna.
From the beginning of the pandemic, the Trudeau government made “firm volume commitments” to purchase 237.22 million doses from seven manufacturers, according to the report.
Commitments include 85 million doses from Pfizer Canada, 52 million doses from Novovax, 44 million doses from Moderna, 20 million doses each from AstraZeneca PLC and Medicago, 9.98 million doses from Janssen Pharmaceuticals, and 6.24 million doses from Sanofi SA. was to ensure
However, Medicago’s contract with Sanofi was terminated “by mutual consent.” No dose was delivered.
and news release On February 3, Medicago’s parent company Mitsubishi Chemical Group announced that the Canadian biopharmaceutical company would “suspend all business.”
The release addresses the evolving COVID-19 vaccine landscape, global demand for vaccines, and “Medicago’s challenges in transitioning to commercial-scale production.”
The “Answers to Questions” report said the liberal cabinet “committed more than $9 billion to procure vaccines and therapeutics and provide international support.”
It added that 189.7 million doses of the COVID vaccine had been delivered to date from the remaining manufacturers.
PACP opposition lawmakers want to know confidential terms detailed in contracts with seven vaccine manufacturers. The Liberal Party will only allow MPs to sign non-disclosure agreements.
The OAG report notes Public Health Canada’s failure to minimize vaccine waste.
“We had 32.5 million doses in stock at the end of May 2022 and, using unclassified public documents, estimated that these doses were worth approximately $1 billion,” the auditor wrote.
“Most of these doses will expire by the end of 2022, so if we don’t use or donate them soon, we will be wasting more.”
On January 31, the federal government announced that 41.5 million vaccines wereconsidered surplusDonations were made in 36 countries, including Mexico (3 million), Nigeria (2.65 million), Bangladesh (2.2 million), Uganda (1.9 million) and Rwanda (1.6 million).